20-May-2022
Download PDF
Torrent Pharma
We hereby inform that the Company has scheduled a teleconference with Investors / Analyst on 25th May 2022 at 07:00 P.M. to discuss the financial performance of the Company for the quarter and year ended 31st March 2022.
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]
Ask Value Research 
Widely read:
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
